t2c-003

N/A

Report date: 2023/02/17 21:06:02

Base Information

Drug Namet2c-003

Drug Alias NameBone marrow-derived progenitor cells therapyt2c-003t2c003-NP

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsDiabetic Neuropathies

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesT2cure

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesT2cure

Active IndicationsN/A

Inactive IndicationsDiabetic Neuropathies

ATC CodeN/A